tradingkey.logo
搜尋

Champions Oncology Inc

CSBR
添加自選
6.130USD
+0.140+2.33%
收盤 07-24 16:00美東報價延遲15分鐘
85.13M總市值
虧損本益比TTM

關於 Champions Oncology Inc 公司

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Champions Oncology Inc簡介

公司代碼CSBR
公司名稱Champions Oncology Inc
上市日期Nov 30, 1988
CEOBrainin (Robert)
員工數量213
證券類型Ordinary Share
年結日Nov 30
公司地址One University Plaza,
城市HACKENSACK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07601
電話12018088400
網址https://championsoncology.com
公司代碼CSBR
上市日期Nov 30, 1988
CEOBrainin (Robert)

Champions Oncology Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--

常見問題

Champions Oncology Inc的前五大股東是誰?

Champions Oncology Inc的前五大股東如下:Mr. Joel Ackerman

有多少機構持有Champions Oncology Inc(CSBR)的股份?

截至2026Q1,共有61家機構持有Champions Oncology Inc的股份,合計持有的股份價值約為6.66M,占公司總股份的47.97% 。與2025Q4相比,機構持股有所增加,增幅為-413745.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有